Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$3.99 - $5.7 $3.29 Million - $4.7 Million
-825,071 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$4.38 - $6.43 $1.4 Million - $2.06 Million
-320,183 Reduced 27.96%
825,071 $4.01 Million
Q2 2020

Aug 13, 2020

BUY
$3.0 - $6.9 $247,917 - $570,209
82,639 Added 7.78%
1,145,254 $6.35 Million
Q1 2020

May 13, 2020

BUY
$2.36 - $9.86 $2.51 Million - $10.5 Million
1,062,615 New
1,062,615 $3.49 Million

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.